Ketamine IV for the prevention of depression in the elderly: new data

Published Date: 13 Mar 2023

Intravenous (IV) ketamine is effective in adults resistant to depression. The response was similar to that seen in younger patients, two new studies show.

Read Full News

Latest News

French Probe Finds No Link Between Baby Death, Nestlé Formula

A judicial inquiry launched in France after the death ⁠of a baby has shown no link with the recalled Nestle infant ⁠formula he had consumed, the Bordeaux prosecutor said.

First-in-Class Tx for Dravet Syndrome Shows Early Success

A first-in-class gene-regulating therapy cut seizures by up to 91% in children with Dravet syndrome in extension studies, raising hopes for a disease-modifying treatment.

Work Disability Risk Can Persist Years After TBI

Traumatic brain injury is linked to a persistently increased risk for work disability irrespective of the severity of the trauma, a new cohort study shows.

Could Red Light Help Tackle Resistant Klebsiella Pneumoniae?

Researchers report that photodynamic therapy increases antibiotic penetration and disrupts resistance mechanisms in laboratory strains.

Gut Infection Disease Care: From GP Clinics to Hospitals

An infectious intestinal disease episode can be noted in both primary care and hospital admissions, with children and older adults having higher odds of admissions during a primary care episode.

Todays Updates

Have the Harms of Lung Cancer Screening Been Exaggerated?

Three medical societies claim recent studies have overestimated the potential harms from lung cancer screening and may be deterring patients. Not everyone agrees.

Pretreatment Liver Tests Often Overlooked in CDK4/6 Therapy

Despite FDA package insert recommendations, most patients with breast cancer who are prescribed CDK4/6 inhibitors do not receive liver function tests before starting treatment.

Alternative Medicine for Breast Cancer: Study Raises Concern

Patients who receive both standard medical treatment and complementary and alternative therapies have higher mortality — possibly due to reduced use of endocrine therapy and radiation.

Todays Updates

Have the Harms of Lung Cancer Screening Been Exaggerated?

Three medical societies claim recent studies have overestimated the potential harms from lung cancer screening and may be deterring patients. Not everyone agrees.

Pretreatment Liver Tests Often Overlooked in CDK4/6 Therapy

Despite FDA package insert recommendations, most patients with breast cancer who are prescribed CDK4/6 inhibitors do not receive liver function tests before starting treatment.

Alternative Medicine for Breast Cancer: Study Raises Concern

Patients who receive both standard medical treatment and complementary and alternative therapies have higher mortality — possibly due to reduced use of endocrine therapy and radiation.

Latest News

A judicial inquiry launched in France after the death ⁠of a baby has shown no link with the recalled Nestle infant ⁠formula he had consumed, the Bordeaux prosecutor said.

A first-in-class gene-regulating therapy cut seizures by up to 91% in children with Dravet syndrome in extension studies, raising hopes for a disease-modifying treatment.

Traumatic brain injury is linked to a persistently increased risk for work disability irrespective of the severity of the trauma, a new cohort study shows.

Researchers report that photodynamic therapy increases antibiotic penetration and disrupts resistance mechanisms in laboratory strains.

An infectious intestinal disease episode can be noted in both primary care and hospital admissions, with children and older adults having higher odds of admissions during a primary care episode.

News All Time

Exclusive-California Preparing Lawsuit over Trump Administration Vaccine Changes

Due Diligence Will Help Hospitalists Land the Right Job

It’s almost like choosing a residency: Choices and determining factors are many. Here’s how to approach the hunt.

Cereulide Found in Recalled Baby Formula, Switzerland Says

Traces of a toxin that can cause ⁠nausea and vomiting were found in two types ⁠of infant formula recalled by France's Danone ⁠earlier this month.

EU: Cereulide Exposure Risk Low After Baby Formula Recalls

The risk of infants being exposed to baby formula contaminated with the cereulide toxin is ⁠now low following recalls across several countries, European authorities say.

US CDC Cancels February Vaccine Adviser Meeting; no New One Set Yet

A U.S. vaccine advisory committee meeting scheduled for later this month by the Centers for Disease Control and Prevention will not be held, with no ⁠new dates announced,...

Updates in Complicated UTI Classification and Treatment

Updates in Complicated UTI Classification and Treatment

Here Today, Safe Tomorrow: Accelerating HIV Prevention With Same-Day and Rapid PrEP Initiation

Here Today, Safe Tomorrow: Accelerating HIV Prevention With Same-Day and Rapid PrEP Initiation

Accelerating HIV Prevention in Primary Care Settings

Accelerating HIV Prevention in Primary Care Settings

Integrating Same-Day or Rapid PrEP Initiation With Substance Use Treatment to Support Holistic Harm Reduction

Integrating Same-Day or Rapid PrEP Initiation With Substance Use Treatment to Support Holistic Harm Reduction

Bringing Rapid PrEP to the Frontlines in Community Pharmacies

Bringing Rapid PrEP to the Frontlines in Community Pharmacies

My Child Was in an Active Shooter Lockdown. This Horror Will Come for Many of Us.

Here are lessons learned about a reality even physicians aren't trained for

Deaths Prompt Clinical Trial Hold; $8,000 'Scorpion' Bill; The Next COVID Vaccine

Health news and commentary gathered by MedPage Today staff

Doctors vs Advanced Practice Providers: A False Fault Line in Medicine

They are teammates working in a system that pits them against each other

Call 911 or Risk Losing the Baby? Raids Force Some Immigrants to Avoid Care.

Immigration sweeps add to the healthcare barriers that some already face

Coffee, Chocolate, and Cellular Aging; Medical Aircraft Crash Kills 5; AAP Sues HHS

Health news and commentary gathered by MedPage Today staff

Are We All as Miserable as the Doctors on 'The Pitt'?

Why some people choose careers that haunt them

Recommended News For You

Targeted First-Line Combo Approved for EGFR-Mutated Lung Cancer

FDA Approves New Drug Combo for RR Multiple Myeloma

Teenagers Frequently Use Delta-8 THC; New Drug-Coated Balloon Treats Blocked Stents.

Why are so many young adults getting cancer?

In Advanced Myxoid Liposarcoma, Is Trabectedin Winning?

Imfinzi + Imjudo, EU approved for patients with advanced lung cancer and non-small cell lung cancer: AstraZeneca

By acquiring T3 Pharma, a leader in bacterial cancer treatment, Boehringer Ingelheim broadens its offering in immunooncology.

Recommended Articles For You

Role of Type I Interferons and KDM1B in Driving Cancer Stemness and Therapeutic Evasion 

Giant Sebaceous Cyst of the Scalp Mimicking a Soft Tissue Tumor: A Case Study 

Vaccines that can help prevent cancer 

Potential of Device-Assisted Therapy in Non-Muscle-Invasive Bladder Cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Prostate Cancer Treatment Associated With Long-Term Complications

2.

Targeted radiation offers promise in patients with metastasized small cell lung cancer to the brain

3.

Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.

4.

Study looks into cancer-related harmful communication.

5.

NEET SS Counseling 2023: MCC provides information on DNB SS Medical Oncology seats available at ESIC Medical College and Hospital Faridabad.

1.

Cancer Care Advances: Metformin, Digital Tools, and Artificial Renal Support

2.

What You Need to Know about Hairy Cell Leukemia: A Comprehensive Guide 

3.

Transplant Oncology and Anti-Cancer Immunosuppressants: The Evolution of a Paradigm in Cancer Care

4.

Matrix Metalloproteinases in Stroke: Broad vs. Selective Inhibition Strategies

5.

Optimizing Melanoma Treatment: Strategies in Diagnosis, Clinical Research, and Physician Training

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII

3.

Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial

4.

Efficient Management of First line ALK-rearranged NSCLC - Part VIII

5.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot